Related Experiment Video

Updated: Mar 17, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

993

Screening for liver fibrosis in psoriatic arthritis: emphasizing metabolic risk

Pankti Mehta1,2,3, Fadi Kharouf1,2,4

  • 1Gladman Krembil Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada.

Rheumatology (Oxford, England)
|March 16, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
FIB-4liver fibrosismetabolic dysfunction-associated steatotic liver diseasepsoriatic arthritis

More Related Videos

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

2.0K
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

1.1K

Related Experiment Videos

Last Updated: Mar 17, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

993
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

2.0K
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

1.1K

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

998
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
998
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

248
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

313
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
313

Articles linked to this work by shared authors, journal, and citation graph.

Characterizing arthritis subtypes in lupus: prevalence, clinical features and role of type I interferon signatures.

Rheumatology (Oxford, England)·2026

Lupus nephritis outcomes when kidney biopsy is not feasible: findings from a tertiary centre inception cohort.

Clinical and experimental rheumatology·2026

Radiographic sacroiliitis progression in psoriatic arthritis.

Rheumatology (Oxford, England)·2026

Do Patients Diagnosed with Psoriatic Arthritis Before or Concurrently With Psoriasis Have Different Disease Phenotypes and Outcomes?

The Journal of rheumatology·2026

Understanding the transition from psoriasis to psoriatic arthritis: the role of targeted therapy.

EULAR rheumatology open·2026

Body mass index and achievement of minimal disease activity in psoriatic arthritis across different classes of advanced therapy.

Rheumatology (Oxford, England)·2026

Cardiovascular and thromboembolic risk in anti-neutrophil cytoplasmic antibody-associated vasculitis: a nationwide matched cohort study by disease, sex, and familial risk.

Rheumatology (Oxford, England)·2026

Inflammaging reshapes the immune ecosystem in IgG4-related dacryoadenitis and sialadenitis.

Rheumatology (Oxford, England)·2026

Baseline disease activity index and forced vital capacity predict clinically meaningful complications and mortality in systemic sclerosis.

Rheumatology (Oxford, England)·2026

Clinical characteristics and long-term outcomes in SLE-myositis overlap syndrome: a controlled retrospective cohort study.

Rheumatology (Oxford, England)·2026

Patterns and changes in lifestyle habits of patients with rheumatoid arthritis during the first three years post-diagnosis.

Rheumatology (Oxford, England)·2026

Cross-sectional stroke risk identification in rheumatoid arthritis: integrating traditional and disease-specific factors.

Rheumatology (Oxford, England)·2026

Energy's long game: thermogenic adipocytes and the metabolic diseases of modern life.

Academia biology·2026

Content validity of the Familial Chylomicronemia Syndrome Symptoms and Impacts Scale (FCS-SIS) for severe hypertriglyceridemia (sHTG).

Patient related outcome measures·2026

Uncovering Immunometabolic Mechanisms and Biomarkers in Diabetic Foot Ulcers: A Multi-omics Approach.

Current pharmaceutical biotechnology·2026

Role of mitochondria-associated ER membranes in lipid metabolism: implications for renal lipotoxicity.

Bioscience reports·2026

[Elucidating mechanism of Biejia-Ruangan Compound Tablets against alcoholic liver disease through gut-liver axis using integrated multi-omics].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026

Epigenetic regulation of fatty acid chain elongation in MAFLD and its implications in the liver-brain axis dysfunction.

Methods in enzymology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us